Showing results (1191-1200 of 1,437) with videos related to
Sort By:
Pageof 144
Cancer Cell|September 14, 2010
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemiaLluis Espinosa, Severine Cathelin, Teresa D'Altri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2021
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid LeukemiaCatherine C Smith, Aaron D Viny, Evan Massi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple MyelomaShwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.Transplantation and Cellular Therapy|January 29, 2023
Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell TherapiesSarah Nikiforow, Matthew J Frigault, Noelle V Frey, et al.Blood|April 18, 2014
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesisRaajit Rampal, Fatima Al-Shahrour, Omar Abdel-Wahab, et al.Blood|January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypePallavi Galera, Deepika Dilip, Andriy Derkach, et al.Leukemia Research|November 4, 2022
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profilingChezi Ganzel, Zhuoxin Sun, Timour Baslan, et al.Blood|June 8, 2017
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical responseMichael D Amatangelo, Lynn Quek, Alan Shih, et al.Cytotherapy|November 27, 2016
Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trialsDavid H McKenna, Darin Sumstad, Diane M Kadidlo, et al.Nature|February 21, 2012
IDH mutation impairs histone demethylation and results in a block to cell differentiationChao Lu, Patrick S Ward, Gurpreet S Kapoor, et al.Pageof 144